UNSPSC 85811936: Introduction of oxazolidinones into nose, via natural or artificial opening

This classification denotes the group of activities that yields a administrative intervention or procedure to introduction of oxazolidinones into nose, via natural or artificial opening. This administrative intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 3E09728

UNSPSC 85811936 Introduction of oxazolidinones into nose, via natural or artificial opening is a Commodity code that shows minimal alignment between its technical specification and recent state and local procurement activity. The recent opportunities tagged under this code do not involve intranasal medication administration; instead, they reflect a broad portfolio of healthcare services including virtual urgent care, occupational health screening, cancer registry support, retinal screening devices, EMT staffing, employee health clinics, nursing home operations, medical directorships, psychological evaluations, and various behavioral health and recovery programs. This mismatch indicates that the code is either misapplied in state and local procurement systems or that its nominal scope does not correspond to how jurisdictions currently classify health service contracts.

State and local issuing bodies across the posted opportunities span county departments (DeKalb County Georgia, Brevard County Florida, Cobb County Georgia, Forsyth County Georgia, Seminole County Florida, Sarasota County Florida, Jackson County Missouri), city governments (Phoenix, Ocala, Boulder, Atlanta, Wichita), regional health authorities (Nevada Health Authority, Inland Empire Health Plan California), special districts (Ventura County, Santa Clara County, Rockland County), school districts (Parkway School District), transit or cooperative entities (Sourcewell Minnesota, H-GAC Texas), and state agencies (Colorado Department of Human Services, Texas HHSC, Illinois Secretary of State, New Jersey Department of Health). Geographic spread spans California, Colorado, Florida, Georgia, Illinois, Kansas, Minnesota, Missouri, Nevada, New Jersey, New York, Oregon, Texas, Virginia, and Washington, with no dominant state concentration. The recent activity shows repeat purchasing bodies including the Nevada Health Authority (PACE operations and rural value acceleration facilitation), San Mateo County (cancer registry and retinal screening), Santa Clara County (travel nurse and temporary health professional staffing), Sedgwick County and Wichita (multiple opioid use disorder treatment tracks), and Ventura County (crisis stabilization and day treatment programs). Representative current solicitations include the Inland Empire Health Plan RFI for 24/7/365 virtual urgent care services due October 31, 2026; Nevada Health Authority's RFP for Program of All Inclusive Care for the Elderly (PACE) operations with proposals due December 10, 2026; San Mateo County's RFP for cancer registry services due October 2, 2026; and Sedgwick County and City of Wichita's multiple RFPs for opioid use disorder treatment, recovery, prevention, and education services across four funding tracks with proposals due September 15, 2026. Because the code's nominal scope does not substantively match the actual procurement activity, this code warrants low pursuit priority unless your firm specializes in intranasal pharmaceutical administration services or can clarify how your offerings map to the misclassified opportunities.